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Summary 
The effects exerted on the in vitro development of antigen-specific T cell lines and T cell clones 
by addition or neutralization of interleukin 12 (I1:12) in lymphocyte bulk culture were examined. 
T  cell lines specific for Dermatophagoides pteronyssinus group I (Der p I) derived in the presence 
of I1:12 exhibited reduced ability to produce I1:4 and increased ability to produce interferon 
"/(IFN-3~),  and developed into Der p  I-specific CD4 § T  cell clones showing a T  helper type 
0 (Th0)- or Thl-, instead of Th2-, like cytokine profile. In contrast, purified protein derivative 
(PPD)-specific T  cell lines derived in the presence of anti-I1:12 antibody exhibited an increased 
ability to produce I1:4 and developed into PPD-specific CD4 + T  cell clones showing a Th0-, 
instead of Thl-, like profile. The influence of IL-12 on the cytokine secretion profile of Der p 
I-specific T cell lines was not prevented by addition to lymphocyte bulk cultures of anti-IFN-y 
antibody, but could be at least partially inhibited by the removal from bulk cultures of CD16 + 
cells.  Thus,  IL-12 and CD16 + cells appear  to have inhibitory effects on the development of 
IL-4-producing cells and to play an inductive role in promoting Thl-like responses. 
D 
ifferential cytokine production by CD4 + Th cells dur- 
ing an immune response plays an important role in 
regulating the nature of the response. In the mouse, CD4 + 
T cells that produce IL-2 and IFN-3~ but little or no IL-4 and 
I1:5 (Thl cells) induce the activation of macrophages to kill 
intracellular parasites,  delayed-type hypersensitivity, and pro- 
duction of IgG2a, but not of IgG1 and IgE. In contrast, re- 
sponses by CD4 + T  cells that predominantly produce I1:4 
and I1:5 (Th2 cells) result in generation of IgG1- and IgE- 
secreting cells and eosinophilia (1).  Human CD4 + T  cell 
clones specific for bacterial antigens (2-4)  and allergen- or 
helminth-specific T  cell clones (2, 3, 5, 6) have been found 
to exhibit  Thl-  or Th2-1ike cytokine production profiles, 
respectively, reminiscent of those described for mouse T cells. 
Both  murine  and  human  CD4 +  T  cells  with  an  inter- 
mediate cytokine profile (Th0) were also described (7-9). Thl 
and  Th2  cells may differentiate  from  a common pool of 
precursors (10) along differentiation pathways controlled, at 
least in part, by cytokines produced by lymphocytes or acces- 
sory cells. In the mouse, IFN-3' promotes differentiation of 
Th precursors into Thl cells, both in vitro (11) and in the 
Leishmania model in vivo (12).  II:4 both in vitro (13)  and 
in vivo (14) has opposite activity, inducing differentiation into 
Th2  cells.  More  recently,  a  reciprocal  regulatory  role  of 
cytokines in the differentiation of human Thl and Th2 cells 
was also demonstrated (15,  16). IL-4 added to bulk lympho- 
cyte culture before cloning shifted the differentiation of purified 
protein derivative (PPD)-specific T cells from the Thl to the 
Th0, or even to the Th2, phenotype (15). In contrast, either 
IFN-'y plus anti-IL-4 antibody or IFN-cr  induced allergen- 
specific T  cells or T  cells specific for helminth constituents 
to differentiate into Th0, or even Thl, instead of Th2 clones 
(15,  16). 
Although IFN-'y is produced by both NK  and T  cells, 
resting NK cells are more ef~cient producers of IFN-'y than 
T  cells in response to I1:2 and other stimuli, due to their 
rapid response and constitutive expression of the I1:2R chain 
(17, 18). A novel heterodimeric cytokine termed natural killer 
cell stimulatory factor (NKSF) or II:12 (19, 20) was recently 
shown to be, together with IFN-3~ and II.-2 (21), one of the 
small groups of cytokines able to rapidly enhance NK cell- 
mediated cytotoxicity. NKSF/I1:12, a product of phagocytic 
cells and B cells,  is active on T  and NK cells,  affecting, in 
addition to cytotoxicity, cellular proliferation and produc- 
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Volume  177  April 1993  1199-1204 tion of lymphokine (19, 22-24).  In particular, NKSF/IL-12 
is a potent inducer of IFN-~/production, acting in this effect 
synergistically with IL-2 and several other inducing stimuli 
(19,  25). 
In this study, we analyzed whether IL-12 affects the in vitro 
differentiation of Th cell subsets. We show that Dermatopha- 
goides pteronyssinus group I (Der p I)-specific T cell lines de- 
rived in the presence of IL-12 exhibited reduced ability to pro- 
duce  IL-4 and  increased  ability  to  produce  IFN-3',  and 
developed  into Der p  I-specific T  cell clones  showing the 
Th0- or Thl-, instead of Th2-, like cytokine profile. In con- 
trast, PPD-specific T cell lines derived in the presence of anti- 
IL-12 antibody exhibited an increased ability to produce IL-4 
and developed into T  cell clones showing Th0-, instead of 
Thl-, like phenotype. The influence of IL-12 on the cytokine 
production profile of Der p I-specific T  cell lines was not 
apparently mediated by its ability to stimulate the produc- 
tion of IFN-3', but could be at least partially inhibited by 
removal from bulk cultures of CD16 + cells. Thus, IL-12 and 
NK cells seem to play an important role in determining the 
development of Thl-like responses. 
Materials and Methods 
Reagents.  PPD was obtained from Istituto Sieroterapico  e Vac- 
cinogeno Sclavo (Siena, Italy). Der p I was obtained from Lofarma 
Allergeni (Milan, Italy). PHA was purchased from Gibco Labora- 
tories (Grand Island, NY) and PMA was from Sigma Chemical 
Co. (St. Louis, MO). Anti-CD3 mAb was purchased from Ortho 
Pharmaceuticals (Raritan, NJ). Anti-CD4,  anti-CD8,  and anti- 
CD16 mAbs were purchased from Becton Dickinson & Co. (Moun- 
tain View, CA). Human rlFN-',/and one of the three anti-IFN-3/ 
mAbs (27.387.33)were purchased from Janssen (Beerse, Belgium). 
The other two mAbs were a generous gift ofC. M. Liang (Biogen, 
Cambridge, MA). Human rlFN-c~2b was purchased from Schering 
Co. (Kenilworth, NJ). Human rib2 was a generous gift of Eu- 
rocetus (Milan, Italy). Human rlL-12 was provided  by Genetics In- 
stitute Inc. (Cambridge, MA) (22). Neutralizing anti-Ib12 mAb 
C8.6 was previously described (26). 
Su~ects.  PBMC  were obtained  from healthy  volunteers  showing 
delayed-type  hypersensitivity  skin reaction to PPD, and from atopic 
house dust mite-sensitive subjects suffering  from atopic dermatitis 
and/or extrinsic asthma and showing immediate-type skin reac- 
tivity to Der p I. 
Generation of Antigen-specific T  Cell Lines and T  Cell Clones. 
PPD- and Der p I-specific T cell lines were generated according 
to a technique previously  described (5, 15, 16). Briefly,  10  ~  PBMC 
in 2 ml RPMI 1640 supplemented with 2 mM t-glutamine, 2  x 
10 -S M 2-ME, and 5% human serum (complete medium) were 
stimulated in 24-well flat-bottomed plates for 5 d with Der p I 
(10/~g/ml) in the absence or presence of IL-12 (100 U/ml) or with 
PPD (10 #g/ml) in the absence or presence of anti-ID12 antibody 
(1/zg/ml),  respectively. Human Ib2 (20 U/ml) was then added 
and cultures were continued for an additional 9 d. Viable T blasts 
were resuspended  in complete medium and tested for their antigen 
specificity  before  cloning procedure. To assess the antigen specificity 
of T cell lines, 2  x  104 T blasts were seeded in microplates and 
cocultured for 48 h with irradiated (6,000 rad) autologous PBMC 
(10  s) in the presence of medium alone, Der p I (1/~g/ml), or PPD 
(1 #g/ml), respectively. After a 16-h pulse with 0.5/zCi [3H]thy- 
midine (Amersham International, Amersham, UK), cultures were 
harvested and radioactivity was measured by liquid scintillation. 
To generate T cell clones, T blasts obtained from antigen-specific 
T cell lines were seeded under limiting dilution conditions (0.3 
cell/well) in 96 round-bottomed microwell plates containing 10  s 
irradiated (6,000 tad) aUogeneic PBMC cells (as feeder cells) and 
PHA (1% vol/vol) in a final volume of 0.2 ml complete medium 
supplemented with II.,2 (20 U/ml) and 10% FCS (Hyclone Labs., 
Logan, UT), as reported elsewhere (5, 15, 16). Growing microcul- 
tures were then supplemented, at weekly intervals, with ID2 (20 
U/ml) and 10  s irradiated feeder cells. The phenotype of T blasts 
from T cell lines and T cell  clones was examined  by flow cytometry 
(16) and their antigen-specificity  assessed by measuring [3H]thymi- 
dine uptake after a 60-h stimulation with the appropriate antigen 
under MHC-restricted conditions (3, 5). When stimulation index 
(ratio between the mean cpm obtained in cultures stimulated with 
APC plus antigen and the mean cpm obtained in cultures with 
APC alone) was >10, responses were considered as positive. Clonal 
efficiency was evaluated according to Taswell (27). 
In some experiments, T cell lines were derived from PBMC sus- 
pensions that had been depleted of CD16 + cells by a double-step 
panning technique, as described by Zubler et al. (28). 
Induction of Cytokine Production by Antigen-specific T  Cell Lines 
and Clones.  To induce the cytokine production,  T blasts were 
resuspended at the concentration of 106/ml in complete medium 
and cultured for 24 h in the presence of PMA (10 ng/ml) plus anti- 
CD3 mAb (100 ng/ml). Cell-free culture supernatants were col- 
lected, filtered, and stored in aliquots at  -70~  until used. 
Quantitation of  lFN-  T and IL.4.  The quantitative  determinations 
of IFN-~/and  ID4 were performed by a commercial ILIA (Cen- 
tocor Inc., Malvern, PA) and ELISA (Quantikine IL & D Systems, 
Minneapolis, MN), respectively.  Levels  of cytokine 3 SD over those 
of control supernatants obtained by stimulation of irradiated feeder 
cells alone were regarded as positive. 
Results 
PBMC from 13 atopic donors were stimulated with Der 
p I in the absence or in the presence of IL-12. The resulting 
cell lines were assessed  for antigen specificity,  cell surface pheno- 
type, and profile of cytokine production (Table 1). Both Ib 
12(-) and IL-12(+) Der p I-specific cell lines showed strong 
and comparable proliferative responses to Der p I under MHC- 
restricted conditions. However, despite the fact that total 
numbers of cells recovered were comparable,  proportions of 
CD8 +  and CD16 +  cells  were  significantly higher  in  ID 
12(+)  than in I1:12(-)  cell lines.  The profile of cytokine 
production in response to stimulation with PMA plus anti- 
CD3 mAb was also different: Der p I-specific I1.-12(+) cell 
lines produced significantly higher concentrations of IFN-3/ 
and significantly lower concentrations of IL-4 than ID12(- ) 
cell lines  (Table 1). 
To test whether Ibl2-induced changes in the cytokine  profile 
of T  cell lines really reflected  a shift in the differentiation 
of Der  p  I-specific  CD4 §  T  cells  toward  the  Thl-like 
profile, T blasts from the II.-12(-) and II~12(+) T cell lines 
derived from one donor were cloned. 20 II.-12(-) and 22 ID 
12(+) Der p I-specific CD4 + T  cell clones were obtained 
and assessed for their ability to produce IFN-v and IL,4 in 
response to stimulation with PMA plus anti-CD3 mAb, As 
shown in Fig. 1 A, the proportion of IL-12(-) T cell clones 
1200  NK Cell Stimulatory  Factor Inhibits IL-4-producing  T Helper Cells Table  1.  Antigen-induced Proliferative Response, Cell Surface Phenotype, and Cytokine Production by Der p 1-specific T  Cell Lines 
Obtained in the Absence or Presence of lL-12 
Proliferative  response* 
Cell surface  phenotype*  Cytokine productions 
APC  + 
Cells  cultured with:  APC  Der  p I  CD4 +  CD8 +  CD16 +  IL-4  IFN-7 
cpm  x  10 -3  cells/ml  x  10 -~  ng/ml  U/ml 
Der p  I  alone  2.1  _+  0.9  43.1  _+  12  1.7  +_  0.5  0.2  _+  0.1  0.2  _+  0.1  1.8  _+  0.3  56  -+  15 
Der  p  I  +  IL-12  3.3  +-  1.6  37.9  _+  7.4  0.9  +_  0.2  0.6  -+  0.2  0.5  +_  0.1  0.5  •  0.1  104  _+  21 
P  NS  NS  <0.05  <0.05  <0.05  <0.001  <0.05 
PBMC from 13 atopic donors were cultured with Der p I (10 #g/ml) alone or Der p I plus IL-12 (100 U/ml), and T cell lines were derived as 
described in Materials and Methods. 
" Der p I specificity of T cell lines was assessed by culturing the cells (2  x  10 4) for 3 d with irradiated autologous PBMC (APC) alone (10  s) or 
in the presence of Der p I (10 #g/ml). 16 h before harvesting, triplicate cultures were pulsed with [3H]thymidine. Results expressed as mean values 
( •  SE) of cpm obtained with  the 13 T cell lines. 
Cell surface phenotype was evaluated by flow cytometer analysis. Mean values (_+  SE) of absolute numbers of different subsets are reported. 
S T blasts (106/ml) were stimulated with PMA (10 ng/ml) plus anti-CD3 antibody (100 ng/ml) and the 24-h culture supernatants assessed for cytokine 
content as described in Materials and Methods. 
able to produce I1:4 (18/20)  was significantly higher  than 
that (7/22) of I1:12(+) clones (p <0.005). Likewise, the mean 
I1:4  concentrations  produced  by  IL-12(-)  clones  were 
significantly higher than that of IL-12(+) clones (2.1  _+  0.4 
vs.  0.8  _+  0.4 ng//zl; p  <0.05).  In contrast,  no significant 
differences between  I1:12(-) and I1:12(+) clones in either 
the proportion of clones able to produce IFN-7 (1_7/20 vs. 
17/22) or the mean concentration oflFN-  7  produced (84  + 
10 vs.  91  _+  17  U//~I)  were observed. 
To  analyze  whether  endogenously  produced  I1:12  can 
influence the cytokine profile of antigen-specific T cells, PPD- 
specific T cell lines were derived from PBMC of four normal 
donors in the presence or absence of neutralizing anti-I1:12 
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Figure  1.  Production of Ib4 and IFN-7 by (A) Der p I-specific  CD4 § 
T cell clones derived from PBMC cultured with Der p I in the absence 
(F-I) or presence  of Ib12 (@) and by (B) PPD-specific  T cell clones derived 
from PBMC cultured with PPD in the absence  (O) or presence  of  anti-lb12 
antibody (A). Clonal T blasts (106/ml) were stimulated for 24 h with 
PMA (10 ng/ml) plus anti-CD3 antibody (100 ng/ml) and supernatants 
were assessed for IL-4  and IFN-7 content, as described in Materials and 
Methods. Dotted lines represent the mean values plus 3 SD of cytokine 
concentrations produced  by irradiated feeder cells alone in response to PMA 
plus anti-CD3 antibody. 
antibody (Table 2).  The ability of PPD-specific T  cell lines 
to produce IFN-7 was not influenced by culturing the cells 
in presence of anti-I1:12 mAb, but  their ability to produce 
IL-4 was significantly enhanced. 8 and 11 PPD-specific T cell 
clones were obtained from the cell lines originated from one 
normal donor in the absence or presence of anti-I1:12 mAb, 
respectively.  As shown in Fig.  1 B,  all PPD-specific T  cell 
clones produced high concentrations of IFN-7 in response 
to stimulation with PMA plus anti-CD3 mAb, but only two 
of those derived in the absence of anti-I1:12 mAb produced 
I1:4.  In contrast,  all  PPD-specific T  cell clones  derived in 
presence of anti-I1:12 antibody produced high IL-4 concen- 
trations. 
The possibility that the inhibitory effect of I1:12 on the 
development of I1:4-producing CD4 + T  cells was mediated 
Table  2.  IL-4  and IFN-7 Production in Response to Stimulation 
with PMA plus Anti-CD3 Antibody  by PPD-specific T  Cell Lines 
Derived in Absence or in Presence of Anti-IL-12  Antibody 
Cells  cultured with:  IL-4  IFN-7 
ng/ml  U/ml 
PPD  0.04  x  0.01  148  •  19 
PPD  +  anti-IL-12 antibody  0.6  •  0.1  155  ~  10 
p  <0.05  N.S. 
PBMC from four normal donors were cuhured in presence of PPD (10 
/zg/ml) alone or PPD plus anti-IL-12  antibody (1/~g/ml) and PPD-specific 
T cell lines then derived as described in Materials and Methods. T blasts 
(10e/ml) from PPD-specific  T cell lines were stimulated with PMA plus 
anti-CD3 antibody and the 24-h culture supernatants were assessed for 
IL-4 and IFN-7 content by ELISA and RIA, respectively, as described 
in Materials and Methods. Mean values _+ SE (,  =  4) are reported. 
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To this end, IL-12(-) and IL-12(+) Der p I-specific T  cell 
lines were derived from two atopic donors by using unfrac- 
tionated PBMC or PBMC that had been depleted of CD16 + 
cells (Table 3). In both donors, the IL-12-induced  inhibitory 
effect on the development of IL-4-producing cells was lower 
when Der p I-specific T cell lines were derived from CD16- 
PBMC  than when derived from total PBMC. 
To test whether the inhibitory effect of IL-12 on the devel- 
opment of Der p 1-specific T cells into IL-4-producing T cell 
lines and clones was mediated by the ability of IL-12 to stimu- 
late IFN-3' production by either NK or T cells, Der p I-specific 
T  cell lines were derived by adding 11112 in the absence or 
presence of anti-IFN-3, antibody. In five experiments, anti- 
IFN-3' antibodies did not prevent the inhibitory activity of 
II_d2 on the development of Der p  I-specific T  cells into 
IL-4-producing T  cell lines (data not shown). 
Discussion 
The results of the present study indicate that 11112 pro- 
motes the in vitro differentiation of Th lymphocytes into cells 
showing a Thl-like profile of cytokine production. Exoge- 
nous rib12, added to bulk lymphocyte cultures from atopic 
donors during in vitro stimulation with Der p I, favored the 
differentiation of antigen-specific T  cell lines  and  dones 
producing high concentrations of IFN-y and no or low con- 
centrations of IL-4, unlike the T cell lines and clones gener- 
ated in  the absence of I1112, which usually produce high 
amounts of I114 and no or low concentrations of IFN-3'. On 
the other hand, the addition in bulk culture of anti-IL-12 Ab 
to neutralize endogenously produced I-b12 favored the differen- 
Table  3.  Removal from Bulk Cultures of CD16 + Cells Partially 
Prevents the Ability of IL-12 to Inhibit  the Development of 
Der p  1-specific T  Cells into IL-4-producing T  Cell Lines 
Bulk culture conditions 
IL-4 produced by 
Der p I-specific 
T cell lines 
Exp.  1  Exp. 2 
ng/ml 
Total PBMC  +  Der p I  4.0  0.5 
Total PBMC  +  Der p I  +  IL-12  0.1  0.02 
CD16--PBMC  +  Der p I  4.0  0.5 
CD16--PBMNC  +  Der p I  +  IL-12  1.5  0.3 
Unfractionated  PBMC or PBMC depleted  of CD16 + cells  were cultured 
with Der p I (10/xg/ml) alone or Der p I plus IL-12 (100 U/ml) and 
T cell lines were derived as described  in Materials and Methods. T blasts 
(106/ml) from Der p I-specific  T cell lines were stimulated  with PMA 
(10 ng/ml) plus anti-CD3 antibody (100 ng/ml) and the 24-h culture 
supernatants were assessed for IL-4 content by ELISA, as described  in 
Materials and Methods. 
tiation of PPD-specific T  cells from normal donors (which 
usually develop into T cell lines and dones producing high 
concentrations of IFN-3' but no Ib4) into T cells producing 
noticeable amounts of I114, as well. The results clearly indi- 
cate that Ib12 in vitro and, possibly,  in vivo is a physiolog- 
ical inducer of the Thl  type of immune responses, with a 
negative effect on the development of Ib4-producing Th cells. 
The ability of 11112 to promote the in vitro development 
of Thl-like cells is at least in part due to its stimulatory effect 
on NK cells. This conclusion is suggested by the fact that: 
(a) both relative and absolute proportions of CD16 + were 
increased in T cell lines derived in the presence of II.,12; and 
(b) removal of CD16 § cells from PBMC bulk cultures par- 
tially prevented the inhibitory effect of 11112 on the develop- 
ment of IL-4-producing Der p I-specific T cells. Because IL- 
12, particularly in association with IL-2, stimulates IFN-3' 
production by both T cells and NK cells (19, 25) and IFN-3' 
inhibits both the development of T cells into IL-4-producing 
cells (15,  16) and the proliferation of Th2 clones (11), the 
IL-12-induced T cell differentiation into Thl-like cells could 
be indirect and mediated by induced IFN-? production. How- 
ever, neutralizing antibodies to IFN-3' failed to overcome the 
IL-12-mediated suppression of Ib4-producing cell develop- 
ment. Although these negative results could be explained by 
the difficulty to block completely the biological activity of 
endogenously produced IFN-% the possibility that 11112 acts 
via an IFN-3'-independent mechanism should be considered. 
IL-12 is produced predominantly by macrophages and other 
MHC class II-positive cells, cell types that have an impor- 
tant role in antigen presentation to Th cells (26). Class II-posi- 
tive PBMC also produce IFN-ot (29), which has similar effects 
on the Th differentiation (16). Thus, it is reasonable to sug- 
gest that, given the capacity of viruses and bacteria to stimu- 
late PBMC production of IFN-ot and IL-12 (26, 29), Th cells 
may be simultaneously presented with processed antigen plus 
cytokines that induce them to differentiate towards the Thl 
phenotype. Indeed, when influenza virus, poly-I-C, or Ba- 
cillus Calmette-Guerin, agents known to stimulate endoge- 
nous IFN-c~ production and possibly I1,-12 secretion, were 
added together with allergen, T cell differentiation was again 
pushed from the Th2 to Th0, or even to Thl, profile (30, 
and Manetti, R., P. Parronchi, R. Biagiotti, M.-P. Piccinni, 
E. Maggi, and S. P,  omagnani, manuscript in preparation). 
Interestingly, the poly-I-C-induced Th0 or Thl differentia- 
tion of allergen-specific T  ceils could be driven to the Th2 
profile only by the simultaneous addition of Ib4, plus anti- 
bodies reactive with IFNw, IFN-ot, and 11112 (30, and Manetti 
et al., manuscript in preparation). These data strongly sug- 
gest that viruses and intracellular bacteria induce Thl-like 
responses because the profile of the natural immune response 
they evoke provides optimum conditions (high concentra- 
tions of IFN-3' and absence of I114) for the development of 
Thl ceils (30). We have recently obtained evidence indicating 
that 11112 production by accessory cells is a requirement for 
optimal production of IFN-3' by lymphocytes and that the 
Th2 products I114 and 11110 are powerful inhibitors of IL-12 
production (26, and D'Andrea, A., M. Aste, M. Kubin, and 
1202  NK Cell Stimulatory  Factor Inhibits IL-4-producing  T Hdper Cells G. Trinchieri, manuscript in preparation). In particular, we 
have shown that Ib12 and TNF produced by accessory cells 
are the cytokines responsible for IFN-'y production by NK 
cells and T cells in response to bacterial stimulation, and that 
the inhibitory effect of II,10 on IFN-3' production is medi- 
ated by its ability to suppress production of these two cytokines 
(D'Andrea et al., manuscript in preparation). It is therefore 
likely that IL-12 represents  a key component in the network 
of cytokines, with complex positive and negative feedback 
regulatory mechanisms that are able to determine the type 
of Th immune response at the very early stages of antigenic 
challenge. 
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